Primary central nervous system lymphomas: Indian experience, and review of literature

Indian Journal of Cancer

Volumn 45, Issue 3, 2008, Pages 112-118

  Paul, T R ^a   Challa, S ^a   Tandon, A ^a   Panigrahi, M K ^a   Purohit, A K ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Diffuse lymphoma; Immunohistochemistry; PCNSLs

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CHILD; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOCOMPETENCE; INDIA; LARGE CELL LYMPHOMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD45; BRAIN NEOPLASMS; CHILD; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOENZYME TECHNIQUES; INDIA; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 57449114731     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.44067     Document Type: Article

References (24)

1. Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol 2006;24:1281-8.
2. th ed. Arnold; 1998. p. 195-237.
3. Eby NL, Grufferman S, Flannely CM, Schold SC Jr, Vogel FS, Burger PC. Increasing inidence of primary brain lymphoma in the US. Cancer 1988;62:2461-5.
4. Kadan-Lottick NS, Skluzacek MC, Gurney JG. Decreasing incidence rates of primary central nervous lymphoma. Cancer 2002;95:193-202.
5. Sarkar C, Sharma MC, Deb P, Singh R, Santosh V, Shankar SK. Primary central nervous system lymphoma: A hospital based study of incidence and Clinicopathological feature from India (1980 -2003). J Neurooncol 2005;71:199-204.
6. Powari M, Radotra B, Das A, Banerjee AK. A study of primary nervous system lymphoma in northern India. Surg Neurol 2002;57:113-6.
7. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993;119:1093-104.
8. Fitzsimmons A, Upchurch K, Batchelor T. Clinical features and diagnosis of primary central nervous system lymphoma. Hematol Oncol Clin North Am 2005;19:689-703.
9. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkln's lymphoma: The Massachusetts General Hospital experience 1958-1989. Cancer 1994;74:1383-97.
10. Muzaffar S, Siddiqul MS, Siddiqui I, Soomro IN, Pervez S, Kayani N, et al. Central nervous system lymphomas: A histologic and Immunophenotypic analysis. J Pak Med Assoc 2000;50:141-4.
11. Hayabuchi N, Shibamoto Y, Onizuka Y. Primary Central Nervous System Lymphoma In Japan: A nationwide Survey. Int J Radiation Oncol Biol Phys 1999;44:265-72.
12. Shibamoto Y, Tsuchida E, Seki K, Oya N, Hasegawa M, Toda Y, et al. Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years. J Cancer Res Clin Oncol 2004;130:351-6.
13. Rubenstein JL, Treseler P, O'Brien JM. Pathology and genetics of primary central nervous system and intraocular lymphoma. Hematol Oncol Clin North Am 2005;19:705-17.
14. Fine HA, Loeffler JS Primary central nervous system lymphoma. In: Canellos GB, Lister TA, Sklar JL, editors. The lymphomas. Philadelphia: WB Saunders; 1998. p. 481-94.
15. Hamilton DK, Bourne TD, Ahmed H, Cousar JB, Mandeli JW, Sheehan JP. Follicular lymphoma of the dura: Case report. Neurosurgery 2006;59:E703-4.
16. Jahnke K, Theil E, Schilling A, Herrlinger U, Weller M, Coupland SE, etal. Low-grade primary central system lymphoma In immunocompetent patients. Br J Haematol 2005;128:616-24.
17. Paulus W, Jellinger K, Morgello S, Deckert-Schluter M. Malignant lymphomas. In: Kleihues P, Cavenee WK, edltors. World Health Classification of tumors,Pathology and Genetics Tumors of the nervous system. Lyon: TARC Press; 2000. p. 197-203.
18. Choi JS, Nam DH, Ko YH, Seo JW, Choi YL, Suh YL, et al. Primary central nervous system lymphoma in Korea: Comparison of B- and T-cell Lymphomas. Am J Surg Pathol 2003;27:919-28.
19. Abrey LE, Batchelor TT, Ferreri AJ, Gospodarowicz M, Pulczynski EJ, Zueca E, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary central nervous system lymphoma. J Clin Oncol 2005;23:5034-43.
20. Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience. J Clin Oncol 2003;21:266-72.
21. Paulus W, Jellinger K. Comparison of integrin adhesion molecules expressed by primary brain lymphomas and nodal lymphomas. Acta Neuropathol 1993;86:360-4.
22. Rao CR, Jain K, Bhatia K, Lakshmaiah KC, Shankar SK. Association of primary central nervous sytem lymphomas with the Ebstein- Barr virus. Neurol India 2003;51:237-40.
23. Camllieri-Broet S, Criniere E, Broet P, Delwail V, Mokhtari K, Moreau A, et al. A uniform activated B-cell like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: Analysis of 83 cases. Blood 2006;107:190-6.
24. Bhagavathi S, Sharatkumar A, Hunter S, Sung L, Kanhere R, Venturina MD, et al. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas. Clin Neuropathol 2008;27:13-20.